Sharp Brains: Brain Fitness and Cognitive Health News

Neuroplasticity, Brain Fitness and Cognitive Health News

Icon

Research on ‘Chemo Brain’: MRI Shows Brain Changes After Chemotherapy

Chemo Brain’: MRI Shows Brain Changes After Chemother­a­py (Med­scape):

- “Breast can­cer sur­vivors who have been treat­ed with chemother­a­py show sig­nif­i­cant changes in brain activ­i­ty, mea­sured by func­tion­al mag­net­ic res­o­nance imag­ing (fMRI), accord­ing to a study pub­lished in the Novem­ber issue of the Archives of Neu­rol­o­gy.”

- “The find­ing val­i­dates patients’ claims of reduced cog­ni­tive func­tion after receiv­ing chemother­a­py, a phe­nom­e­non referred to as “chemo brain,” said lead author Shel­li R. Kesler, PhD, from Stan­ford Uni­ver­si­ty School of Med­i­cine in Cal­i­for­nia.”

Link to study Pre­frontal Cor­tex and Exec­u­tive Func­tion Impair­ments in Pri­ma­ry Breast Can­cer (Archives of Neu­rol­o­gy):

  • Objec­tives To exam­ine dif­fer­ences in pre­frontal-exec­u­tive func­tion between breast can­cer (BC) sur­vivors with and with­out a his­to­ry of chemother­a­py treat­ment com­pared with healthy con­trol women and to deter­mine the asso­ci­a­tions between pre­frontal cor­tex deficits and behav­ioral impair­ments, as well as cer­tain demo­graph­ic and dis­ease vari­ables.
  • Design Obser­va­tion­al study.
  • Set­ting Uni­ver­si­ty-based research facil­i­ty.
  • Par­tic­i­pants Twen­ty-five women with BC who had received chemother­a­py, 19 women with BC who had not received chemother­a­py, and 18 healthy female con­trols, all matched for age and oth­er demo­graph­ic vari­ables.
  • Results Women with BC demon­strat­ed sig­nif­i­cant­ly reduced acti­va­tion in the left mid­dle dor­so­lat­er­al pre­frontal cor­tex and pre­mo­tor cor­tex com­pared with healthy con­trols. The chemother­a­py group also demon­strat­ed sig­nif­i­cant­ly reduced left cau­dal lat­er­al pre­frontal cor­tex acti­va­tion and increased per­se­ver­a­tive errors and reduced pro­cess­ing speed com­pared with the oth­er 2 groups. Reduced left cau­dal lat­er­al pre­frontal cor­tex acti­va­tion was sig­nif­i­cant­ly cor­re­lat­ed with high­er dis­ease sever­i­ty and ele­vat­ed sub­jec­tive exec­u­tive dys­func­tion in the chemother­a­py-treat­ed women. Old­er age and low­er edu­ca­tion­al lev­el were asso­ci­at­ed with increased exec­u­tive func­tion impair­ment in the chemother­a­py group.
  • Con­clu­sions These find­ings pro­vide fur­ther evi­dence of neu­ro­log­i­cal impair­ment asso­ci­at­ed with pri­ma­ry BC irre­spec­tive of treat­ment his­to­ry. The left cau­dal lat­er­al pre­frontal region may be par­tic­u­lar­ly vul­ner­a­ble to the effects of chemother­a­py and/or dis­ease sever­i­ty and may rep­re­sent a nov­el bio­mark­er of sub­jec­tive exec­u­tive dys­func­tion in chemother­a­py-treat­ed women. Fur­ther­more, neg­a­tive effects of chemother­a­py on brain func­tion may be exac­er­bat­ed by such fac­tors as increased age and low­er edu­ca­tion­al lev­el.

To learn more, see relat­ed arti­cles on Chemo Brain.

Leave a Reply...

Loading Facebook Comments ...

2 Responses

  1. FredrickM says:

    yes it is true that left cau­dal lat­eral pre­frontal region may be par­tic­u­larly vul­ner­a­ble to the effects of chemother­apy and/or dis­ease sever­ity and may rep­re­sent a nov­el bio­marker of sub­jec­tive exec­u­tive dys­func­tion in chemother­a­py-treat­ed women. Thanks for the post.

Leave a Reply

Categories: Cognitive Neuroscience, Health & Wellness

Tags: , , , , , , , , , , , , , ,

Watch All Recordings Now (40+ Speakers, 12+ Hours)

About SharpBrains

As seen in The New York Times, The Wall Street Journal, BBC News, CNN, Reuters and more, SharpBrains is an independent market research firm tracking health and performance applications of brain science.

Follow us and Engage via…

twitter_logo_header
RSS Feed

Search for anything brain-related in our article archives